drugset / Trial / NCT05132699
Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder
Phase 1/2
Completed
21 enrolled
The University of Texas Health Science Center at San Antonio
National Center for Advancing Translational Sciences (NCATS) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary goal of this pilot project is to demonstrate the safety and feasibility of using Cannabidiol (CBD) in combination with standard of care prolonged exposure (PE) psychotherapy to reduce PTSD symptoms.
Timeline
- Start
- 2022-04-04
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 250 mg | Oral |